
VTYX
Healthcare · Biotechnology · $1.00B market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2025
EPS trend, 90 days to now · -8.3% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 4 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| May 7, 2026 | Time not confirmed | -0.41 | 0.00 | +100.0% |
| Mar 19, 2026 | Time not confirmed | -0.37 | 0.00 | +100.0% |
| Nov 7, 2025 | Time not confirmed | -0.45 | -0.32 | +28.9% |
| Aug 7, 2025 | Time not confirmed | -0.46 | -0.38 | +17.4% |
| Jun 5, 2025 | After the close | -0.69 | -0.39 | +43.5% |
| Feb 27, 2025 | Time not confirmed | -0.54 | -0.41 | +24.3% |
| Nov 4, 2024 | After the close | -0.52 | -0.50 | +3.8% |
| Aug 9, 2024 | Time not confirmed | -0.58 | -0.45 | +22.4% |
| May 9, 2024 | After the close | -0.69 | -0.62 | +10.1% |
| Feb 27, 2024 | After the close | -0.90 | -0.79 | +12.2% |
| Nov 9, 2023 | After the close | -0.90 | -0.92 | -2.2% |
| Aug 10, 2023 | After the close | -0.71 | -0.91 | -28.2% |
| May 11, 2023 | After the close | -0.65 |
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases. Its pipeline includes small molecule therapeutics to treat inflammation across cardiometabolic disorders, neurodegenerative diseases, and inflammatory disorders. The company's portfolio of NLRP3 inhibitors includes VTX958, a selective allosteric…
| -0.68 |
| -4.6% |
| Mar 23, 2023 | After the close | -0.64 | -0.62 | +3.1% |
| Nov 3, 2022 | After the close | -0.44 | -0.59 | -34.1% |
| Aug 15, 2022 | After the close | -0.45 | -0.39 | +13.3% |
| May 12, 2022 | After the close | -0.52 | -0.45 | +13.5% |
| Mar 23, 2022 | Before the open | -1.00 | -0.36 | +64.0% |
| Nov 17, 2021 | After the close | -0.36 | -3.17 | -780.6% |
| Jun 30, 2021 | Time not confirmed | 0.00 | -0.92 | — |
| Mar 31, 2021 | Time not confirmed | 0.00 | -0.92 | — |
| Jun 30, 2020 | Time not confirmed | 0.00 | -0.12 | — |
| Mar 31, 2020 | Time not confirmed | 0.00 | -0.12 | — |